[ 18 F]T807, a novel tau positron emission tomography imaging agent for Alzheimer's disease

Neuropathological stageing of Alzheimer-related changes.

Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123 · cited 1×

Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction

Yung-Chi, C., & Prusoff, W. H. (1973) · Biochemical Pharmacology · doi:10.1016/0006-2952(73)90196-2 · Cited by 12,922

Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade

Jack, C. R., Knopman, D. S., Jagust, W. J., Shaw, L. M., Aisen, P. S., Weiner, M. W., Petersen, R. C., & Trojanowski, J. Q. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70299-6 · Cited by 4,806

Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐B

Klunk, W. E., Engler, H., Nordberg, A., Wang, Y., Blomqvist, G., Holt, D. P., Bergström, M., Savitcheva, I., Huang, G., Estrada, S., et al. (2004) · Annals of Neurology · doi:10.1002/ana.20009 · Cited by 4,496

Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease

Arriagada, P. V., Growdon, J. H., Hedley-Whyte, E. T., & Hyman, B. T. (1992) · Neurology · doi:10.1212/wnl.42.3.631 · Cited by 2,668

Neurodegenerative Tauopathies

Lee, V. M.-Y., Goedert, M., & Trojanowski, J. Q. (2001) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.24.1.1121 · Cited by 2,480

Tau-mediated neurodegeneration in Alzheimer’s disease and related disorders

Ballatore, C., Lee, V. M.-Y., & Trojanowski, J. Q. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2194 · Cited by 2,174

Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects

Shaw, L. M., Vanderstichele, H., Knapik‐Czajka, M., Clark, C. M., Aisen, P. S., Petersen, R. C., Blennow, K., Soares, H., Simon, A., Lewczuk, P., et al. (2009) · Annals of Neurology · doi:10.1002/ana.21610 · Cited by 2,065

Alzheimer’s Dementia

Melnick, V. L., & Dubler, N. N. (1985) · Contemporary Issues in Biomedicine, Ethics, and Society · doi:10.1007/978-1-4612-5174-3 · Cited by 1,986

Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP

Lewis, J., Dickson, D. W., Lin, W.-L., Chisholm, L., Corral, A., Jones, G., Yen, S.-H., Sahara, N., Skipper, L., Yager, D., et al. (2001) · Science · doi:10.1126/science.1058189 · Cited by 1,611

A Cooperative Model for Symmetric Ligand Binding to Protein Fibrils

Smith, M. S., DeGrado, W. F., Grabe, M., & Shoichet, B. K. (2025) · Biochemistry · doi:10.1021/acs.biochem.5c00068 · Cited by 3

Molekulare Bildgebung von Tau- und α-Synuclein-Pathologien: technische Fortschritte, Herausforderungen und Potenziale

Gnörich, J. S., Franzmeier, N., & Brendel, M. (2026) · Fortschritte der Neurologie · Psychiatrie · doi:10.1055/a-2823-2465 · Cited by 2

Neuropsychological profiles and neural correlates in typical and atypical variants of Alzheimer disease: A systematic qualitative review

Fredes-Roa, C., Gutiérrez-Barría, F., Ramírez-Bruna, C., Cigarroa, I., Martella, D., Julio–Ramos, T., Méndez‐Orellana, C., & Toloza–Ramirez, D. (2022) · Neurology Perspectives · doi:10.1016/j.neurop.2022.07.007 · Cited by 2

Medicinal (Radio) Chemistry: Building Radiopharmaceuticals for the Future

Pijeira, M. S. O., Nunes, P. S. G., Chaviano, S. L., Diaz, A. M. A., DaSilva, J. N., Ricci‐Júnior, E., Alencar, L. M. R., Chen, X. S., & Santos‐Oliveira, R. (2023) · Current Medicinal Chemistry · doi:10.2174/0929867331666230818092634 · Cited by 2

PET Tracers for Beta-Amyloid and Other Proteinopathies

Nordberg, A. K. (2014) · Springer eBooks · doi:10.1007/978-3-642-42014-6_8 · Cited by 2

Nuclear Imaging in Frontotemporal Dementia

Reesink, F. E., Stormezand, G. N., Dierckx, R. A. J. O., & Deyn, P. P. D. (2014) · Springer eBooks · doi:10.1007/978-3-642-54307-4_15 · Cited by 2

Current and future prospects of nuclear medicine in dementia

Ito, K., Inui, Y., Kizawa, T., Kimura, Y., & Kato, T. (2017) · Rinsho Shinkeigaku · doi:10.5692/clinicalneurol.cn-001016 · Cited by 2

Regioselective Transition‐Metal‐Free Synthesis of Diverse Benzothiazoles by Thermally Induced Cyclization of ortho ‐Halobenzanilides

Jang, K. S., Shin, D. S., Song, H. R., Lee, B. S., & Yoon, D. (2017) · ChemistrySelect · doi:10.1002/slct.201701130 · Cited by 2

SPECT and PET of the Brain

Kimura, Y., Kato, T., Ito, K., & Ichise, M. (2020) · Springer eBooks · doi:10.1007/978-3-030-39457-8_4 · Cited by 2

Comparison of MRI-based and PET-based image pre-processing for quantification of 11C-PBB3 uptake in human brain

Yousefzadeh‐Nowshahr, E., Winter, G., Bohn, P., Kneer, K., Arnim, C. A. F. V., Otto, M., Solbach, C., Anderl‐Straub, S., Polivka, D., Fissler, P., et al. (2021) · Zeitschrift für Medizinische Physik · doi:10.1016/j.zemedi.2020.12.002 · Cited by 2

60 Years of Achievements by KSNM in Neuroimaging Research

Kim, J. S., Son, H. J., Oh, M., Lee, D. Y., Kim, H. W., & Oh, J. S. (2022) · Nuclear Medicine and Molecular Imaging · doi:10.1007/s13139-021-00727-1 · Cited by 2

Functional MRI Studies of Memory in Aging, Mild Cognitive Impairment, and Alzheimer’s Disease

Zhu, J. K., Risacher, S. L., Wishart, H. A., & Saykin, A. J. (2023) · Springer eBooks · doi:10.1007/978-3-031-10909-6_30 · Cited by 2

PET Imaging Agents for Alzheimer’s Disease

Choi, S., Plöessl, K., Zhu, L., & Kung, H. F. (2017) · Topics in medicinal chemistry · doi:10.1007/7355_2016_18 · Cited by 2

High‐yield synthesis of a tau PET radioligand and its nonradioactive ligand using an alternative protection and deprotection strategy

Kim, H., & Choe, Y. S. (2020) · Journal of Labelled Compounds and Radiopharmaceuticals · doi:10.1002/jlcr.3894 · Cited by 2

Radiopharmaceuticals in Molecular Imaging

Vallabhajosula, S. (2015) · Encyclopedia of Computational Neuroscience · doi:10.1007/978-1-4614-6675-8_537 · Cited by 2

Positron Emission Tomography (PET) Imaging

Ponto, L. L. B. (2018) · Wiley eBooks · doi:10.1002/9781118772034.ch9 · Cited by 2

A screening platform based on epitope editing for drug discoveryPreprint

Zhu, B., Yang, J., Van, R. S., Ran, K. R., Yin, K., Liang, Y., Shen, X., Yin, W. H., Choi, S. H., Lu, Y., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/838896 · Cited by 2

Classics in Neuroimaging: Untangling the Role of Tau in Neurodegenerative Disorders Using Positron Emission Tomography

Witek, J. A., Brooks, A. F., & Scott, P. J. H. (2022) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.2c00519 · Cited by 2

Click Chemistry: The Certainty of Chance (Nobel Lecture)**

Sharpless, K. B., Finn, M. G., & Kolb, H. C. (2025) · Angewandte Chemie · doi:10.1002/ange.202501229 · Cited by 1

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451

Zhan, Y., Zuo, F., Zhang, Z., Wu, X., Dai, Y., Jiao, T., Shi, Q., Wang, Z., & Zhang, G. (2025) · Journal of Visualized Experiments · doi:10.3791/67574 · Cited by 1

Distribution-Guided Multi-tracer Brain PET Synthesis from Structural MRI with Class-Conditioned Weighted Diffusion

Yu, M., Lalush, D. S., Monroe, D. C., Giovanello, K. S., Lin, W., Yap, P., Mihalik, J. P., & Liu, M. (2025) · Lecture notes in computer science · doi:10.1007/978-3-032-04965-0_15 · Cited by 1

Synthesis and Evaluation of Radioiodinated [125I]7‐Iodo‐5H‐Pyrido[4,3‐B]Indole ([125I]CTAU) in Postmortem Human Alzheimer's Disease Brain

McNamara, C. C., Biju, A. P., Hipolito, E., Nguyen, N.-H.-T., Liang, C., & Mukherjee, J. (2026) · Journal of labelled compounds & radiopharmaceuticals · doi:10.1002/jlcr.70003 · Cited by 1

Evaluation of [18F]MK-6240 binding to tau protein in postmortem human brains of Down syndrome and Alzheimer’s disease and assessment of off-target (non-tau) binding

Karim, F., Biju, A. P., Liang, C., Santos, C. J., Rajarethenam, M., & Mukherjee, J. (2026) · Acta Neuropathologica Communications · doi:10.1186/s40478-026-02267-1 · Cited by 2

Neuropathological perspectives on neuroinflammation and tau molecular imaging in frontotemporal lobar degeneration

Gatto, R. G., Youssef, H., Fu, M., Reichard, R. R., Lowe, V. J., Whitwell, J. L., Josephs, K. A., & Uruk, G. (2026) · Discover Neuroscience · doi:10.1186/s13064-026-00292-3 · Cited by 1

Alzheimer’s Disease and the Search for Environmental Risk Factors

Kukull, W. A. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800228-5.00015-7 · Cited by 1

Molecular Imaging and Precision Medicine in Dementia and Movement Disorders

Mallik, A. K., Drzezga, A. E., & Minoshima, S. (2016) · PET Clinics · doi:10.1016/j.cpet.2016.08.003 · Cited by 1

Diagnostic Prospectives with Tau Protein and Imaging Techniques to Detect Development of Chronic Traumatic Encephalopathy

Naskar, A., Jayanty, D., Head, K. Z., Khanna, G. L., Vatsalya, V., & Banerjee, A. (2023) · Journal of Behavioral and Brain Science · doi:10.4236/jbbs.2023.134005 · Cited by 1

Traits and Trammels of Tau Tracer Imaging

Villemagne, V. L., Lopresti, B. J., Doré, V., Minhas, D. S., Gogola, A., Nadkarni, N. K., Mason, N. S., Bourgeat, P., López, O. L., Ikonomović, M. D., et al. (2023) · Springer eBooks · doi:10.1007/978-3-031-35098-6_6 · Cited by 1

Imaging of biological processes using positron emission tomography and single-photon emission computed tomography

Ji, A., & Cheng, Z. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-95223-1.00014-x · Cited by 1

In Situ Labeling of Pathogenic Tau Using Photo-Affinity Chemical Probes

Nie, P., Wu, Y., Robinson, J. L., Mekala, S., Lee, V. M. ‐., & Li, Y. (2025) · ACS Chemical Biology · doi:10.1021/acschembio.5c00073 · Cited by 1

The Default Network of the Brain

Dijk, K. R. A. V., & Drzezga, A. E. (2014) · Springer eBooks · doi:10.1007/978-3-642-54307-4_8 · Cited by 1

Neuroimaging Advances in Alzheimer's Disease

Schonhaut, D. R., & Rabinovici, G. D. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-800105-9.00017-2 · Cited by 1

Tau Imaging in Preclinical Alzheimer’s Disease

Edison, P. (2018) · Neuromethods · doi:10.1007/978-1-4939-7674-4_13 · Cited by 1

Quantification of Tau Load in Alzheimer’s Disease Clinical Trials Using Positron Emission Tomography

Timmers, T., van Berckel, B. N. M., Lammertsma, A. A., & Ossenkoppele, R. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-7704-8_15 · Cited by 1

In Vivo Positron Emission Tomography of Extrastriatal Non-Dopaminergic Pathology in Parkinson Disease

Müller, M. L. T. M., & Bohnen, N. I. (2018) · Contemporary clinical neuroscience · doi:10.1007/978-3-319-78926-2_7 · Cited by 2

Update on Alzheimer’s Disease

Jellinger, K. A. (2015) · EMJ Neurology · doi:10.33590/emjneurol/10311025 · Cited by 1

Alzheimer’s Disease

Filippi, M., & Agosta, F. (2021) · Springer eBooks · doi:10.1007/978-3-030-66773-3_1 · Cited by 1

Nuclear Imaging in Frontotemporal Dementia

Reesink, F. E., Stormezand, G. N., Dierckx, R. A. J. O., & Deyn, P. P. D. (2020) · Springer eBooks · doi:10.1007/978-3-030-53168-3_15 · Cited by 1

Applied clinical neuroimaging in cerebral amyloid angiopathy and spontaneous intracerebral haemorrhage

Charidimou, A. (2015) · UCL Discovery (University College London) · Cited by 1

Degradation of Mnemonic Networks in Aging and Alzheimer’s Disease

Chhatwal, J. P. (2015) · Digital Access to Scholarship at Harvard (DASH) (Harvard University)

Imaging as a Diagnostic Tool in Parkinson’s Disease

Wikström, J., & Danfors, T. (2016) · Methods in pharmacology and toxicology · doi:10.1007/978-1-4939-3560-4_15

Chronic traumatic encephalopathy and white matter

Filley, C. M. (2016) · Cambridge University Press eBooks · doi:10.1017/cbo9781139548878.017

Alzheimer’s Disease and white matter

Filley, C. M. (2016) · Cambridge University Press eBooks · doi:10.1017/cbo9781139548878.016

Imaging Approaches to Cerebral Cortex Pathology

Bartha, R., & Lee, T.-Y. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-801942-9.00003-3

Biomarkers of Alzheimer’s Disease

Saeed, U., Swardfager, W., Black, S. E., & Masellis, M. (2017) · Mental health and illness worldwide · doi:10.1007/978-981-10-0370-7_8-1

Tau PET in Neurodegenerative Diseases Manifesting Dementia

Okamura, N., Harada, R., Furumoto, S., & Kudo, Y. (2017) · Springer eBooks · doi:10.1007/978-4-431-55133-1_10

Your brain scan may be a reflection of your genes

Lowe, V. J., Kalari, K. R., & Kandimalla, K. K. (2018) · Brain · doi:10.1093/brain/awy226

Evaluation of the Feasibility of Screening Tau Radiotracers Using an Amyloid Biomathematical Screening Methodology

Nai, Y., & Watabe, H. (2018) · Computational and Mathematical Methods in Medicine · doi:10.1155/2018/6287913

Apolipoprotein E polymorphism and hippocampal atrophy across the spectrum of Alzheimer’s disease and dementia with Lewy bodies

Saeed, U. (2018) · TSpace (University of Toronto)

PET Biomarkers for Tau Pathology

Leuzy, A., Heurling, K., & Schöll, M. (2019) · Springer eBooks · doi:10.1007/978-3-030-27779-6_13

Associations of Amyloid Deposition and FDG Uptake in Aging and Cognitively Impaired Elders With and Without Moderate to Severe Periventricular White Matter Hyperintensities Using Simple Machine Learning Techniques

Zukotynski, K. (2020) · TSpace (University of Toronto)

Moving from the Lab to the Patient in A sia

Yoon, D. (2020) · doi:10.1002/9781119500575.ch16

Imaging of FTLD-tau Using [18F]AV-1451

Burke, C. (2017) · TSpace (University of Toronto)

Longitudinal tau PET using [ 18 F]flortaucipir: Comparison of (semi)quantitative parametersPreprint

Visser, D., Tuncel, H., Ossenkoppele, R., Yaqub, M. M., Wolters, E. E., Timmers, T., Weltings, E., Coomans, E. M., den Hollander, M. E., van der Flier, W. M., et al. (2021) · medRxiv · doi:10.1101/2021.08.27.21262740

The Influence of Age and Alzheimer’s Pathology on Hippocampal Function

Marks, S. M. (2017) · eScholarship (California Digital Library)

Traumatic Brain Injury and Chronic Traumatic Encephalopathy

Aranha, M. R., Coutinho, A. M., Leite, C. D. C., & Buchpiguel, C. A. (2021) · Springer eBooks · doi:10.1007/978-3-030-82367-2_40

Tau Imaging in Neurodegenerative Dementia

Ponisio, M. R., Iranpour, P., & Benzinger, T. L. S. (2021) · Springer eBooks · doi:10.1007/978-3-030-82367-2_12

PET Chemistry: Radiopharmaceuticals

Roß, T. L., & Ametamey, S. M. (2021) · Springer eBooks · doi:10.1007/978-3-030-65245-6_8

The Default Network of the Brain

Dijk, K. R. A. V., & Drzezga, A. E. (2020) · Springer eBooks · doi:10.1007/978-3-030-53168-3_7

Neuroimaging in dementia

Misquitta, K., Rosen, H. J., & Tartaglia, M. C. (2016) · Cambridge University Press eBooks · doi:10.1017/9781139924771.004

Thirty years post-injury: Impact of traumatic brain injury on later Alzheimer’s disease

Takashi, H., & Hanayama, K. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-823347-4.00022-1

Densité des dépôts de la protéine Tau versus activité métabolique cortico-cérébrale chez des patients atteints de maladie d’Alzheimer ou de pathologies apparentées

Pasquesoone, H., Vercouillie, J., Balageas, A., Gissot, V., Dupont, A.-C., Arlicot, N., Maia, S., Beaufils, É., & Ribeiro, M. J. (2022) · Médecine Nucléaire · doi:10.1016/j.mednuc.2022.05.001

Additional file 1 of Comparison of regional flortaucipir PET with quantitative tau immunohistochemistry in three subjects with Alzheimer’s disease pathology: a clinicopathological study

Pontecorvo, M. J., Keene, C. D., Beach, T. G., Montine, T. J., Arora, A., Devous, M. D., Navitsky, M. A., Kennedy, I. A., Joshi, A. D., Lu, M., et al. (2020) · Figshare · doi:10.6084/m9.figshare.12486836

Alzheimer's Disease is Associated with Robust Neuroingflammation in the Hippocampus of WomenPreprint

Acosta‐Martínez, M., Carter, V., Nessim, A., Dhawan, J., Beach, T. G., Serrano, G. E., Sundermann, E. E., & Biegon, A. R. (2024) · SSRN Electronic Journal · doi:10.2139/ssrn.4834013

PET Biomarkers for Tau Pathology

Leuzy, A., Heurling, K., & Schöll, M. (2024) · Springer eBooks · doi:10.1007/978-3-031-54196-4_13

PROGRESS IN IDENTIFYING BINDERS TO DISEASE-RELEVANT TAU AND α-SYNUCLEIN WITH THERAPEUTIC OR DIAGNOSTIC POTENTIAL

Capacci, A. G., & Paras, N. A. (2024) · Medicinal chemistry reviews · doi:10.1021/mc-2024-vol59.ch02

Optimised Synthesis of [19f]-Florzolotau and its Fluorine-18 Radiolabelling PrecursorPreprint

Montgomery, A. P., Harvey-Latham, E. D., Kassiou, M., & Danon, J. J. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5108131

A century of Alzheimer's disease: Merging neuropathology with in vivo biomarkers

Harrison, T. M., & Jagust, W. J. (2025) · Elsevier eBooks · doi:10.1016/b978-0-12-822240-9.00013-2

Selective imaging probes for differential detection of pathological tau polymorphs in tauopathies

Bisi, N., Pinzi, L., & Rastelli, G. (2025) · Drug Discovery Today · doi:10.1016/j.drudis.2025.104352

Manufacturing Challenges and Radiopharmaceutical Application of 18F-labeled Heterocycles for PET Imaging

Vavsari, V. F., Golmohammadi, F., & Balalaie, S. (2025) · Royal Society of Chemistry eBooks · doi:10.1039/9781837677139-00411

An open dataset of cerebral tau deposition in young healthy adults based on [ 18 F]MK6240 positron emission tomographyPreprint

Lam, J., Rodríguez‐Cruces, R., Arafat, T., Royer, J., Chen, J., Dascal, A., Sahlas, E., Pana, R., Hopewell, R., Hsiao, C. H.-H., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.06.13.655622

Imaging Markers of Amyloid and Tau in Alzheimer Disease

Tarawneh, R. M. (2025) · Springer eBooks · doi:10.1007/978-3-031-80849-4_20

Discovery of a Novel Tau Pet Tracer: Design, Synthesis, Radio-Labeling, and Preclinical EvaluationsPreprint

Kuang, W., Yao, D., Zhang, N., Yao, Q., Xie, Y., Tian, R., & Wu, X. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5382845

Discovery of a Novel Tau Pet Tracer: Design, Synthesis, Radio-Labeling, and Preclinical EvaluationsPreprint

Kuang, W., Yao, D., Zhang, N., Yao, Q., Xie, Y., Tian, R., & Wu, X. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5382846

Cerebrospinal Fluid, Molecular Neuroimaging, and Blood Biomarkers of Neurodegenerative Disease: Past, Present, and Future

Soleimani‐Meigooni, D. N., & Rabinovici, G. D. (2025) · Cambridge University Press eBooks · doi:10.1017/9781108985055.006

Additional file 1 of Deep learning-based amyloid PET positivity classification model in the Alzheimer’s disease continuum by using 2-[18F]FDG PET

Kim, S., Lee, P., Oh, K. T., Byun, M. S., Yi, D., Lee, J. H., Kim, Y. K., Ye, B. S., Yun, M. J., Lee, D. Y., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14767314

Additional file of Comparison of regional flortaucipir PET with quantitative tau immunohistochemistry in three subjects with Alzheimer’s disease pathology: a clinicopathological study

Pontecorvo, M. J., Keene, C. D., Beach, T. G., Montine, T. J., Arora, A., Devous, M. D., Navitsky, M. A., Kennedy, I. A., Joshi, A. D., Lu, M., et al. (2020) · Figshare · doi:10.6084/m9.figshare.12872198

Additional file 1 of Early tau detection in flortaucipir images: validation in autopsy-confirmed data and implications for disease progression

Kotari, V., Southekal, S. S., Navitsky, M. A., Kennedy, I. A., Lu, M., Morris, A., Zimmer, J. A., Fleisher, A. S., Mintun, M. A., Devous, M. D., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26571886

Additional file 1 of Preliminary mechanistic insights of a brain-penetrant microtubule imaging PET ligand in a tau-knockout mouse model

Damuka, N., Orr, M. E., Bansode, A. H., Krizan, I. M., Miller, M. D., Lee, J., Macauley, S. L., Whitlow, C. T., Mintz, A., Craft, S., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20381869

Additional file 5 of Early tau detection in flortaucipir images: validation in autopsy-confirmed data and implications for disease progression

Kotari, V., Southekal, S. S., Navitsky, M. A., Kennedy, I. A., Lu, M., Morris, A., Zimmer, J. A., Fleisher, A. S., Mintun, M. A., Devous, M. D., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26571898

Additional file 3 of Early tau detection in flortaucipir images: validation in autopsy-confirmed data and implications for disease progression

Kotari, V., Southekal, S. S., Navitsky, M. A., Kennedy, I. A., Lu, M., Morris, A., Zimmer, J. A., Fleisher, A. S., Mintun, M. A., Devous, M. D., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26571892

Additional file 4 of Early tau detection in flortaucipir images: validation in autopsy-confirmed data and implications for disease progression

Kotari, V., Southekal, S. S., Navitsky, M. A., Kennedy, I. A., Lu, M., Morris, A., Zimmer, J. A., Fleisher, A. S., Mintun, M. A., Devous, M. D., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26571895

Additional file 1 of Characterization of an APP/tau rat model of Alzheimer’s disease by positron emission tomography and immunofluorescent labeling

Filip, T., Mairinger, S., Neddens, J., Sauberer, M., Flunkert, S., Stanek, J., Wanek, T., Okamura, N., Langer, O., Hutter‐Paier, B., et al. (2021) · Figshare · doi:10.6084/m9.figshare.16822759

Additional file 2 of Early tau detection in flortaucipir images: validation in autopsy-confirmed data and implications for disease progression

Kotari, V., Southekal, S. S., Navitsky, M. A., Kennedy, I. A., Lu, M., Morris, A., Zimmer, J. A., Fleisher, A. S., Mintun, M. A., Devous, M. D., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26571889

Discovery of a novel tau PET tracer: Design, synthesis, radio-labeling, and preclinical evaluations

Yao, D., Zhang, N., Yao, Q., Xie, Y., Tian, R., Wu, X., & Kuang, W. (2026) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2025.118542

Evaluation of [18F]MK-6240 binding to tau protein in postmortem human brains of Down syndrome and Alzheimer’s disease and assessment of off-target (non-tau) bindingPreprint

Karim, F., Biju, A. P., Liang, C., Santos, C. J., Rajarethenam, M., & Mukherjee, J. (2026) · Research Square · doi:10.21203/rs.3.rs-8463304/v1

Mapping individual molecular connectomes in Alzheimer's disease

Xu, Z., Mijalkov, M., Sun, J., Chang, Y., Sala, A., Volpe, G., Severino, M., Veronese, M., Ptacek, S. G., Pereira, J. B., et al. (2026) · Alzheimer s & Dementia · doi:10.1002/alz.71310

Complexes métalliques pour utilisation en imagerie médicale : application à la maladie d’Alzheimer

Porqueras, D. S. D. (2016) · theses.fr (ABES) · doi:10.70675/b908263ez07c9z441ez94d8zc53fbd818c56

Radiosynthèse de 3/5-[18F]-fluoropyridines à partir de précurseurs iodoniums

Pauton, M. (2018) · doi:10.70675/5cd40305z31c2z4729zaaf5ze0ff1526ec66

Joint Reconstruction of Longitudinal Positron Emission Tomography Studies for Tau Protein Imaging

Tiss, A. (2019) · theses.fr (ABES) · doi:10.70675/c487be06z4e17z48c0za864zfe62a434cd75

Early memory deficits and extensive brain network disorganization in the AppNL-F/MAPT double knock-in mouse model of familial Alzheimer's disease

Borcuk, C. (2021) · theses.fr (ABES) · doi:10.70675/c316f2dcz54d3z41cfzb3f5z99c7b2d3cd95 · Cited by 1

Methods for improved brain PET quantification using super-resolution and non-negative matrix factorization

Chemli, Y. (2023) · doi:10.70675/0bcd3403z4f6dz4c17zae48z52a9ad43f53a

Apport de l'IRM multimodale pour le diagnostic différentiel des syndromes parkinsoniens

Chougar, L. (2022) · doi:10.70675/eebdb441z4314z48f5zab1aze3d95f0d4e54

Molecular Imaging and Theragnosis Using Radiopharmaceuticals

García-Varela, L., Núñez, V. P., & Aguiar, P. (2026) · Springer handbooks · doi:10.1007/978-3-032-01636-2_33

Advancing tau-PET imaging in Alzheimer's disease

Therriault, J. (2026) · The Lancet · doi:10.1016/s0140-6736(26)00809-3

The importance of tau tracers in the diagnosis of neurodegenerative diseases

Sadeghian, S., & Seradj, S. H. (2026) · Results in Chemistry · doi:10.1016/j.rechem.2026.103531

Tau Disaggregation by a CNS-Permeable Small Molecule Reduces Fibril and Oligomer Burden and Preserves Proteostasis and BehaviorPreprint

Mostowfi, N., Foreman, R. P., Wang, J., Khoury, R., Albanese, A., Ma, Q. L., Cohn, W., Petzinger, G. M., Jakowec, M. W., Ahmed, S., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.06.09.731185

Impact of reduced 18F-MK6240 PET/MR acquisition duration on image quality and tau pathology assessment in patients with cognitive impairment

Liao, K., Li, J., Jiao, F., Zhang, Z., Xu, L., Wang, Z., Li, W., & Pang, H. (2026) · EJNMMI Physics · doi:10.1186/s40658-026-00914-z

Tau-mediated Mechanisms in Alzheimerʼs Disease Pathogenesis

Narayanappa, T. S., Ananthanarayana, V., & Chinnathambi, S. (2026) · Molecular Neurobiology · doi:10.1007/s12035-026-06057-7

Chemical probes for Alzheimer’s disease targets

Aiken, S., Zarganes‐Tzitzikas, T., & Brennan, P. E. (2026) · Essays in Biochemistry · doi:10.1042/ebc20260014

Looking for the link between plaques and tangles

Duyckaerts, C. J. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2003.12.014 · Cited by 53

Early clinical PET imaging results with the novel PHF-tau radioligand [F-18]-T807

Chien, D. T., Bahri, S., Szardenings, A. K., Walsh, J. C., Mu, F., Su, M.-Y., Shankle, W. R., Elizarov, A., & Kolb, H. C. (2013) · Journal of Alzheimer's Disease · doi:10.3233/jad-122059 · Cited by 651

A highly selective and specific PET tracer for imaging of tau pathologies

Zhang, W., Arteaga, J., Cashion, D. K., Chen, G., Gangadharmath, U., Gomez, L. F., Kasi, D., Lam, C., Liang, Q., Liu, C., et al. (2012) · Journal of Alzheimer's Disease · doi:10.3233/jad-2012-120712 · Cited by 195

Early Clinical PET Imaging Results with the Novel PHF-Tau Radioligand [F18]-T808

Chien, D. T., Szardenings, A. K., Bahri, S., Walsh, J. C., Mu, F., Xia, C. A., Shankle, W. R., Lerner, A. J., Su, M., Elizarov, A. M., et al. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-130098 · Cited by 683

171 Early Clinical PET Imaging Results with the Novel PHF-Tau Radioligand [F18]-T808

Chiena, D. T., Szardeningsa, A. K., Bahrib, S., Walsha, J. C., Mua, F., Xiaa, C., Shanklec, W. R., Lernerd, A. J., Sub, M.-Y., Elizarova, A., et al. (2013)